The market for orthopedic pharmaceuticals worldwide was valued at USD 916.80 million in 2019 and is anticipated to reach USD 2429.38 million by 2026, growing at a CAGR of 5.9% from 2020 to 2026. The market's expansion is attributable to an increase in the frequency of orthopedic diseases including fractures, an ageing population with osteoporosis and osteoarthritis, an increase in the number of roads, and rapid technological improvements.

The market for sports medicine is anticipated to increase at a CAGR of 5.7% from USD 5.5 billion in 2020 to USD 7.2 billion by 2025. The market for sports medicine is expected to grow as a result of factors like increased sports injury rates, a steady intake of new goods and treatment options, advancements in the field of regenerative medicine, and rising desire for minimally invasive procedures.

Market for Global Rheumatology Therapeutics, By Drug Class (DMARDs, NSAIDs, corticosteroids, and uric acid medications), Disease Indication (rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, and ankylosing spondylitis), and Distribution Method (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Industry Trends and Forecast to 2028 by Country (United States, Canada, Mexico, Germany, Italy, Netherlands, Spain, France, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa).